stockaxis

Sai Life Sciences Ltd.

Pharmaceuticals & Drugs

IPO Details
  • Issue Type Book building
  • Price range Rs.522-549
  • Market Lot 27
  • Total Equity Shares 38829848
  • Face Value Rs. 1
  • Listing Date Dec 18, 2024
IPO Timeline
Opening date Dec 11, 2024
Closing date Dec 13, 2024
Listing Date Dec 18, 2024

IPO Details

We are an innovator-focused, contract research, development, and manufacturing organization (“CRDMO”). We provide end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (“NCE”), to global pharmaceutical innovator companies and biotechnology firms. We possess both (a) discovery / contract research (“CRO”) and (b) chemistry, manufacturing, and control (“CMC”) / contract development and manufacturing organization (“CDMO”) capabilities. We are the fastest-growing Indian CRDMOs among listed Indian peers in terms of revenue CAGR as well as EBITDA CAGR from Financial Year 2022 to Financial Year 2024. (Source: F&S Report) Our CRDMO platform provides multiple entry points for us to acquire customers in the intermediate stages of their new drug discovery to commercialization journey. We are also one of the few CRDMOs to have a unique delivery model of having research laboratories for discovery and development located near overseas innovation hubs at Watertown (Greater Boston, MA), United States (“US”) and Manchester, United Kingdom (“UK”), complemented by large-scale research laboratories and manufacturing facilities in cost competitive locations in India. (Source: F&S Report) During the Financial Year 2024, we served more than 280 innovator pharmaceutical companies, including 18 of the top 25 pharmaceutical companies (in terms of revenue for the calendar year 2023), across regulated markets, including the US, the UK, Europe and Japan. (Source: F&S Report) During the Financial Year 2024, we also provided CRO services to more than 60 customers on an ongoing basis, for their integrated drug discovery programs. As of March 31, 2024, our CDMO product portfolio included more than 150 innovator pharmaceutical products, including 38 products that were supplied for manufacturing of 28 commercial drugs.

Projects

1. Project Name: Repayment/ prepayment, in full or part, of all or certain outstanding borrowings availed by our Comp

Project Cost: 6000

Promoters

Prmoters Name

1. Kanumuri Ranga Raju

2. Krishnam Raju Kanumuri

3. Kanumuri Mytreyi

4. Sai Quest Syn Pvt Ltd.

5. Marigold Partners

6. Sunflower Partners

7. Tulip Partners and Lily Partners

Prmoters Holdings
  • Pre Share Capital: 77704340
  • Pre Promoter Holding: 40.48
  • Offer to Public: 38829848
  • Post Share Capital: 73293890
  • Post Promoter Holding: 35.24

Registrar

Registrar Name:Karvy Computershare Pvt Ltd
Phone: 91-040-67161500
Email: einward.ris@karvy.com
Website: www.karvy.com

Lead Managers

  • Kotak Mahindra Capital Co Ltd
  • IIFL Securities Ltd.
  • Jefferies India Pvt Ltd.
  • Morgan Stanley India Co Pvt Ltd

Subscription Details

Field Description Field Value
Ipo Code 3010
Total Equity 38829848

Field Description Field Value
No of Shares Offered/Reserved For Qualified Institutional Buyers 10671763
No of Shares Bid For Qualified Institutional Buyers 330125058
Total No of Shares Bid For Qualified Institutional Buyers 30.93
No of Shares Offered/Reserved For Foreign Institutional Buyers 0
No of Shares Bid For Foreign Institutional Buyers 206308674
Total No of Shares Bid For Foreign Institutional Buyers 0.00
No of Shares Offered/Reserved For Mutual Fund 0
No of Shares Bid For Mutual Fund 66843954
Total No of Shares Bid For Mutual Fund 0.00
No of Shares Offered/Reserved For Qualified Institutional Buyers - Others 0
No of Shares Bid For Qualified Institutional Buyers - Others 56972430
Total No of Shares Bid For Qualified Institutional Buyers - Others 0.00

Field Description Field Value
No of Shares Offered/Reserved For Non-Institutional Buyers 8447426
No of Shares Bid For Non-Institutional Buyers 41522058
Total No of Shares Bid For Non-Institutional Buyers 4.92
No of Shares Offered/Reserved For Corporate 0
No of Shares Bid For Corporate 4267377
Total No of Shares Bid For Corporate 0.00
No of Shares Offered/Reserved For Individuals 0
No of Shares Bid For Individuals 34015356
Total No of Shares Bid For Individuals 0.00
No of Shares Offered/Reserved For Individuals - Others 0
No of Shares Bid For Individual Others 3239325
Total No of Shares Bid For Individual Others 0.00

Field Description Field Value
No of Shares Offered/Reserved For Retail Individual Investor 19710659
No of Shares Bid For Retail Individual Investor 26912412
Total No of Shares Bid For Retail Individual Investor 1.37
No of Shares Offered/Reserved For Retail Individual Investor - Cutoff 0
No of Shares Bid For Retail Individual Investor - Cutoff 22117239
Total No of Shares Bid For Retail Individual Investor - Cutoff 0.00
No of Shares Offered/Reserved For Retail Individual Investor 0
No of Shares Bid For Retail Individual Investor 4795173
Total No of Shares Bid For Retail Individual Investor 0.00

Field Description Field Value
No of Shares Offered/Reserved For Employee 0
No of Shares Bid For Employee 0
Total No of Shares Bid For Employee 0.00
No of Shares Offered/Reserved Employee - Cutoff 0
No of Shares Bid For Employee - Cutoff 0
Total No of Shares Bid For Employee - Cutoff 0.00
Total No of Shares Bid Offered/Reserved For Employee 0
No of Shares Bid Offered/Reserved For Employee 0
Total No of Shares Bid For Employee 0.00

Field Description Field Value
No of Shares Offered/Reserved For All 38829848
No of Shares Bid For All 398559528
Total 10.26